25th Annual San Diego Heart Failure Winter Symposium

25th Annual San Diego Heart Failure Winter Symposium is organized by Complete Conference Management (CCM) and will be held from Jan 17 - 18, 2025 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.

Description:
The 25th Annual San Diego Heart Failure Winter Symposium - New Strategies for Detection, Prevention and Treatment of Heart Failure This year’s meeting will provide a comprehensive overview of contemporary management strategies for patients with heart failure. The talks, panel discussions and case presentations will focus on best practices and recent guideline recommendations as interpreted by a faculty that is made up of leaders in the field. Over the two day course, we will review the full range of management options for patients throughout the spectrum of heart failure, starting with Stage A patients who are identified by the presence of risk factors for cardiovascular disease and extending to those with changes in cardiac structure and function but who remain asymptomatic (Stage B). Additional sessions will provide in depth discussion of the management of symptomatic Stage C patients with HFpEF and HFrEF and the treatment options that are available for patients with Stage D or end-stage heart failure. New approaches for diagnosing heart failure and identifying specific groups of patients that require special management considerations (such as amyloid, hypertrophic and genetic cardiomyopathies) will be highlighted as will strategies for successful implementation of guideline directed therapies. Faculty members will discuss the role of drugs, devices and surgical interventions with a focus on the most effective treatment approaches and share their experience in how to best implement them.

The Symposium combines didactic talks with panel discussions and case presentations to provide a full and balanced perspective of relevant management issues. An addition to the Symposium this year is the input that will be offered by patients who will provide their own unique insights on the various treatment options that are available. Also new to the Symposium are the Coffee with the Faculty and ‘Fascinoma’ sessions that will be held on Friday and Saturday mornings, respectively. These sessions are designed specifically to allow the audience an opportunity to interact with the faculty in a relaxed informal setting while getting the insight of experts in the field on management issues and challenging cases. Our goal, as always, is to provide cutting edge information in a format that will enhance adaption of the knowledge that is gained into clinical practice.

Objectives:
At the conclusion of this activity, participants should be able to:

• Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
• Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
• Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.